Thomas T. Kubic

On a daily basis, many individuals unknowingly risk death or serious injury to their health by taking counterfeit drugs.  As executive director of the Pharmaceutical Security Institute (PSI), I see first-hand how counterfeiters thrive in countries where the anti-counterfeiting laws are weak; the drug regulatory agencies are underfunded and understaffed; and legal sanctions are ineffective.